Inhibrx Biosciences, Inc. (INBX)

NMS – Real vaqt narxi. Valyuta: USD

94.81

-0.50 (-0.52%)

Yopilishda: Jun 26, 2026, 4:00 PM EDT

94.81

-0.00 (-0.00%)

Bozordan keyin: Jun 26, 2026, 4:31 PM EDT

Kompaniya haqida

Inhibrx Biosciences, Inc., klinik bosqichdagi biofarmatsevtika kompaniyasi, hayot uchun xavfli kasalliklarga chalingan odamlar uchun biologik dorilarni ishlab chiqish bilan shug'ullanadi. Uning terapevtik nomzodlari orasida 1-bosqichda bo'lgan INBRX-109, operatsiya qilinmaydigan yoki metastatik an'anaviy xondrosarkomani davolash uchun o'lim retseptoriga 5 ni nishonga olgan tetravalent terapevtik nomzod; va metastatik qattiq o'simta, mayda hujayrali bo'lmagan o'pka saratoni, melanoma, bosh va bo'yin mayda hujayrali o'pka saratoni, oshqozon yoki oshqozon-esofageal birikma adenokarsinomasi, buyrak hujayrali karsinoma va urotelial karsinoma davolash uchun OX4 ni nishonga olgan geksavalent sdAb-asosli terapevtik nomzod INBRX-106 mavjud. Inhibrx Biosciences, Inc. 2024 yilda tashkil etilgan va La Jolla, Kaliforniyada joylashgan.

Asosiy rahbarlar

Ism	Lavozim
Dr. Ashraf Amanullah Ph.D.	Executive VP & Chief Technical Operations Officer
Dr. Carlos Bais Ph.D.	EVP & Chief Scientific Officer
Dr. Josep Garcia Ph.D.	Executive VP & Chief Clinical Development Officer
Mr. David J. Matly M.B.A.	President
Mr. Mark Paul Lappe	Founder, CEO & Chairman
Ms. Bonne Adams M.B.A.	Vice President of Operations